<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04497181</url>
  </required_header>
  <id_info>
    <org_study_id>I2017001223</org_study_id>
    <nct_id>NCT04497181</nct_id>
  </id_info>
  <brief_title>Study on the Effectiveness and Safety of Coil System for Intracranial Aneurysm Embolization</brief_title>
  <official_title>Study on the Effectiveness and Safety of Coil System for Intracranial Aneurysm Embolization</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      &quot;Study on the effectiveness and safety of the coil system for the treatment of intracranial&#xD;
      aneurysms embolization&quot; was sponsored by Zhuhai Tongqiao Medical Technology Co., Ltd. The&#xD;
      trial design is: prospective, multi-center, randomized, open, parallel positive control, and&#xD;
      non-inferiority test. Purpose: To compare the data obtained by using the coil system produced&#xD;
      by Zhuhai Tongqiao Medical Technology Co., Ltd. and the Axium Detachable Coil produced by&#xD;
      Medtronic for the embolization of intracranial aneurysms to evaluate the effectiveness and&#xD;
      safety of coil system for intracranial aneurysms embolization.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      &quot;Study on the effectiveness and safety of the coil system for the treatment of intracranial&#xD;
      aneurysms embolization&quot; was sponsored by Zhuhai Tongqiao Medical Technology Co., Ltd. The&#xD;
      team leader is Shanghai Changhai Hospital and the Second Affiliated Hospital of Zhejiang&#xD;
      University School of Medicine. The trial design is: prospective, multi-center, randomized,&#xD;
      open, parallel positive control, and non-inferiority test. Purpose: To compare the data&#xD;
      obtained by using the coil system produced by Zhuhai Tongqiao Medical Technology Co., Ltd.&#xD;
      and the Axium Detachable Coil produced by Medtronic for the embolization of intracranial&#xD;
      aneurysms to evaluate the effectiveness and safety of coil system for intracranial aneurysms&#xD;
      embolization. Sample: 228 cases. The subjects will be randomly assigned to the test group or&#xD;
      the control group, with 114 cases in each group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2010</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Embolization success rate</measure>
    <time_frame>6 months</time_frame>
    <description>Embolization success rate at 6-month after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Aneurysm recurrence rate</measure>
    <time_frame>6 months</time_frame>
    <description>Aneurysm recurrence rate at 6-month after surgery</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Intracranial Aneurysm</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Coil embolization surgery</intervention_name>
    <description>Embolization of aneurysms with various coils system</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  An intracranial aneurysm was diagnosed by DSA examination of whole cerebral blood&#xD;
             vessels, and it is planned to use a coil for the embolization of the target aneurysm&#xD;
&#xD;
          -  The subject can understand the purpose of the research, show sufficient compliance&#xD;
             with the research protocol, and sign an informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Multiple aneurysms&#xD;
&#xD;
          -  Blood alveolar aneurysm, fusiform aneurysm, pseudoaneurysm, dissecting aneurysm,&#xD;
             infectious aneurysm with arteriovenous malformation&#xD;
&#xD;
          -  mRS score ≥ 3&#xD;
&#xD;
          -  Hunt and Hess rating≥4&#xD;
&#xD;
          -  Emergency ruptured aneurysms who need stent&#xD;
&#xD;
          -  The target aneurysm has previously been treated with vascular embolization or surgery&#xD;
&#xD;
          -  Patients with severe stenosis of the tumor-bearing artery&#xD;
&#xD;
          -  PLT&lt;60*10⁹ or INR&gt;1.5&#xD;
&#xD;
          -  Having vital organ failure or other serious diseases&#xD;
&#xD;
          -  Received major surgery within 30 days before enrollment, or planned to undergo surgery&#xD;
             within 90 days after enrollment&#xD;
&#xD;
          -  History of allergy or contraindications to antiplatelet drugs, anticoagulant drugs,&#xD;
             anesthetics, or contrast agents&#xD;
&#xD;
          -  Patiens with a history of allergies to platinum and tungsten metals&#xD;
&#xD;
          -  Life expectancy &lt;12 months&#xD;
&#xD;
          -  Pregnant or breastfeeding women&#xD;
&#xD;
          -  Participated in other drug or device clinical trials within 1 month before signing the&#xD;
             informed consent&#xD;
&#xD;
          -  Other situations that the researcher judges are not suitable for inclusion&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>jianmin zhang, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of neurosurgery</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>jianmin zhang, M.D.</last_name>
    <phone>+86 0571 87784755</phone>
    <email>zjm135@zju.edu.cn</email>
  </overall_contact>
  <location>
    <facility>
      <name>Jianmin Zhang</name>
      <address>
        <city>Hangzhou</city>
        <state>Zhejiang</state>
        <zip>310000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jianmin Zhang, M.D., Ph.D.</last_name>
      <phone>+86 0571 87784755.</phone>
      <email>zjm135@zju.edu.cn</email>
    </contact>
    <investigator>
      <last_name>Jianmin Zhang, M.D.，Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>July 26, 2020</study_first_submitted>
  <study_first_submitted_qc>July 29, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 4, 2020</study_first_posted>
  <last_update_submitted>July 29, 2020</last_update_submitted>
  <last_update_submitted_qc>July 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 4, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>intracranial aneurysms embolization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

